Lindsey Skelton

Papers

Total Citations

H-Index

About

Lindsey Skelton is a leading researcher in urologic oncology, with a primary focus on advancing prostate cancer diagnostics through robotic-assisted technologies. Her most cited work, a 2019 prospective analysis of robotic targeted MRI-US fusion prostate biopsy, introduced the centroid targeting approach—a method that enhances precision in transperineal biopsies by enabling pre-programmed, standardized sampling schemes. This study, which has garnered 38 citations, demonstrated the clinical viability of robotically assisted biopsies in a cohort of 86 men, significantly improving the accuracy of cancer detection while reducing operator variability. Skelton’s contributions have been instrumental in bridging the gap between imaging and interventional robotics, offering a reproducible framework that minimizes invasiveness and optimizes tissue sampling. Her research not only underscores the potential of fusion-guided techniques to transform diagnostic workflows but also lays the groundwork for broader adoption of automated biopsy systems. By validating these technologies in prospective settings, Skelton has positioned herself at the forefront of precision medicine in urology, with implications for reducing unnecessary biopsies and improving patient outcomes. Her work continues to influence both clinical practice and the development of next-generation robotic tools.